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Abstract: Radiotherapy is still a long way from personalizing cancer treatment plans, and its effective-
ness depends on the radiosensitivity of tumor cells. Indeed, therapies that are efficient and successful
for some patients may be relatively ineffective for others. Based on this, radiobiological research is
focusing on the ability of some reagents to make cancer cells more responsive to ionizing radiation, as
well as to protect the surrounding healthy tissues from possible side effects. In this scenario, zebrafish
emerged as an effective model system to test for radiation modifiers that can potentially be used for
radiotherapeutic purposes in humans. The adoption of this experimental organism is fully justified
and supported by the high similarity between fish and humans in both their genome sequences and
the effects provoked in them by ionizing radiation. This review aims to provide the literature state of
the art of zebrafish in vivo model for radiobiological studies, particularly focusing on the epigenetic
and radiomodifying effects produced during fish embryos’ and larvae’s exposure to radiotherapy
treatments.
Keywords: epigenetics; radiomodifiers; radiotherapy; zebrafish; embryogenesis
1. Introduction
1.1. The Role of Radiotherapy in Cancer Treatment
In the most common radiation-therapy (RT) approach used in the clinical setting, an
external beam delivers high-energy rays (photons, protons or particle radiation) to the
tumor. Ionizing radiation (IR), used in conventional RT, consists of high- or low-energy
photon/electromagnetic beams (X- and γ-rays), with typical lineareEnergy Ttansfer (LET)
values in the range of 0.2 to 5 keV/µm. This allows the delivery of controlled doses of
radiation to kill a defined tumor mass, limiting collateral damage to the surrounding
tissue [1].
In the last 25 years, a strong technological advancement has been developed, allowing
modern RT equipment to release more specific and targeted dose intensities, with concave
or complex shapes [2]. Nevertheless, RT plans for distinct tumor types are still customized
exclusively from a conformational point of view, not considering the clinical and molecular
heterogeneity of the tumors [3]. Consequently, nonaggressive tumors receive an overdose,
with side effects on the surrounding healthy tissues, while the more aggressive tumor sub-
types receive an total dose insufficient to avoid the onset of loco-regional recurrence due to
tumor radioresistance [4]. It follows that the personalization of therapeutic plans primarily
requires improving the cancer cells’ radiosensitivity. Among the methods explored, one
attractive possibility is given by the combination of RT and the use of molecules able to
increase the RT success. Accordingly, in recent years the attention has been strongly focused
on the use of either natural compounds or anthropogenic chemicals as RT coadjuvants,
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with the aim of increasing both normal tissue radioprotection and tumor cell radiosensiti-
zation [5,6]. While radioprotectors are often antioxidant compounds designed to reduce
the damage in normal and tumor tissues caused by radiation, radiosensitizers increase
the indirect radiation effects by promoting free-radical fixation or inhibiting activation of
detoxification pathways.
1.2. Zebrafish as a Model in Radiobiology
Most of the radiobiological experimentation is carried out on different types of primary
or immortalized human or animal cell cultures. To reach valid conclusions, however,
this approach needs to be complemented by further analysis, using appropriate in vivo
preclinical models that take into account the complex physiological phenomena related
to organisms in their entirety. Among mammalian models, the mouse (Mus musculus)
is widely used, due to several advantages, such as their high genetic similarity with
humans, and the possibility of conducting cell type-specific knockout experiments and
electrophysiology and behavioral studies [7]. In addition, mice are well-established models
for reverse genetics, aging and injury paradigms, allowing access to a large collection of
mutants and antibodies [8]. On the other hand, their major disadvantages relate to their
high cost, the frequent maintenance and manual cleaning of the cages, their relatively long
gestation time of about 20 days, and parental sacrifice, in the case of genetic manipulation
or other experimental evaluations at the early stages of development.
The zebrafish (Danio rerio) model provides the opportunity to bridge the ever-present
gap between in vitro studies and rodents. Zebrafish, a small fish living in Southeast Asian
freshwater habitats, is increasingly used as an in vivo study model in the context of basic
research, toxicology and translational medicine [9]. Being a vertebrate, it shows a close
genetic relationship to humans, with a shared 70% zebrafish–human overall orthology
assignment [10]. In this regard, the zebrafish is an excellent experimental tool for human
cancer research, essentially, because many key genes involved in cell cycling, oncogen-
esis and tumor suppression are conserved between the two species [10,11]. Additional
advantageous features make zebrafish a valid alternative to the conventional mouse model
for the development of numerous therapeutic methods, including RT. First, these fish are
quite small (adults are about 2–3 cm long), of ready abundance and accessibility and they
can be easily maintained in the laboratory without excessive cost. Their high fertility rate,
combined with short generation time and large number of offspring, reduces the time to
produce experimental replicates, thereby increasing their potential for statistical validity. It
follows that zebrafish embryos provide a rapid and simple system to screen novel agents
to be used as radio-protectors/sensitizers.
Importantly, numerous approaches have been developed to reproduce and study
human cancer diseases, for example, through the localized microinjection of tumor cells
into zebrafish and subsequent pharmacological approaches aimed at evaluating possible
therapeutic protocols by chemical screens and in vivo imaging [12]. Thanks to the exter-
nal fertilization and optical clarity of wild-type embryos and some adult mutant lines,
the in vivo non-invasive visualization of fluorescent, tagged cells, or the evaluation of
processes, such as angiogenesis, tumor growth/reduction or cell-cell interaction, have
become simplified assays [13]. Worth mentioning, the immature adaptive immune system
of zebrafish embryos accepts the transplantation and survival of human cancer cells with
no need for immunosuppression [14]. In addition, their main organs, such as the brain,
eyes, spinal cord, vasculature and hematopoietic systems, are already defined at 48 h
post-fertilization (hpf)—a much shorter time than that of mice—allowing rapid evaluation
of RT efficacy on early embryos. The choice of the zebrafish embryo is ideal for this kind of
study, since embryogenesis is the most radiosensitive stage of the vertebrate life cycle, due
to rapid cell division [15]. Furthermore, the aqueous environment in which the embryos
develop promotes homogeneous distribution of the irradiation dose. Finally, thanks to an
irradiation size less than 1 mm between the cell monolayer culture and subcutaneous tu-
mors or normal tissue organs, zebrafish embryos could be used to study relative biological
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effectiveness (RBE) and for detailed investigations on the RBE–LET relationship, both for
low- and high-LET radiation types [16].
2. Epigenetic Changes Inflicted by Radiation during Zebrafish Embryogenesis
Irradiation of zebrafish embryos determines a series of specific morphological anoma-
lies during development, including spinal curvature, body-length shortening, pericardial
edema, inhibition of yolk-sac resorption, microphthalmia and microcephaly [11,17]. Addi-
tional effects pertain to variation in mortality and hatching rates, behavioral activity and the
expression of genes related to DNA damage, cell death and detoxification pathways [18].
Altogether, these abnormalities are broadly comparable to those observed in mammals
exposed to therapeutic or accidental radiation [19,20]. Numerous studies have also shown
that fish cells not directly traversed by IR exhibit similar responses to those of directly
irradiated cells, a phenomenon already known as the bystander effect [21]. This effect
relies on cell communication through gap junctions or by the emission of soluble factors,
such as reactive oxygen species (ROS) or cytokines, and could eventually lead to cell death,
neoplastic transformation, and genomic instability [21].
Several studies have suggested that genomic instability induced by IR could be
related to epigenetic effects, since IR are able to induce modulation of spatiotemporal
gene expression patterns without variation in the DNA sequence. In this respect, it is
widely recognized that mitochondria play a fundamental role in the IR response, and that
dysfunction of these organelles leads to oxidative stress which, in turn, affects epigenetic
regulation [22].
In zebrafish, epigenetic marks such as DNA methylation, histone post-translational
modifications and microRNA relative abundance undergo normal changes during em-
bryogenesis [13,23]. For example, the global 5-methylcytosine level starts to increase after
3.3 hpf and reaches a plateau between 6 and 96 hpf. Accordingly, knock down of DNA
methyltransferases (DNMT) -1 and -3b, by means of antisense morpholino oligonucleotides,
confirmed the importance of these two enzymes during zebrafish embryogenesis. In fact,
DNMT1 appears to play the role of an essential genome regulator, because it modulates
the DNA double-strand-breaks-repair rate and suppresses the abnormal activation of the
DNA damage response (DDR) in the absence of exogenous injury [24].
Compared with unperturbed control embryos, exposure to γ rays at 0.7, 7, 70 and
550 mGy/d induced a statistically significant dose-dependent increase in DNA cytosine
methylation, both in directly irradiated embryonic zebrafish fibroblasts or in cells subjected
to bystander effects [25]. A concordant study showed the radiosensitizing effect of pretreat-
ment, with the DNA methylating agent Temozolomide, before the administration of 10 Gy
γ rays on 24 hpf zebrafish embryos containing U251 xenotransplants [26].
Covalent post-translational modifications (PTMs) of specific amino acid residues on
histones are frequently associated with either normal or IR-induced changes between
transcriptionally permissive and repressive chromatin states in a wide variety of cell types
and organisms, including zebrafish [27,28]. A recent study showed that exposure of early
zebrafish embryos to 32.7 mGy γ rays caused a specific enrichment of histone H3 trimethy-
lation at lysine 4 (H3K4me3), 9 (H3K9me3) and 27 (H3K27me3) on three genes localized on
distinct chromosomes, namely hepatocyte nuclear factor 4 alpha, geminin DNA replication
inhibitor, and vascular endothelial growth factor Ab [29]. In particular, the increased
amount of the negative epigenetic marks H3K9me3 and H3K27me3 suggests that IR could
mainly impact on heterochromatinization as a mechanism for genome repression [29].
Finally, although microRNAs are absent in the early fish zygote, miR-125b acts as a
negative regulator of the p53 network, both in zebrafish and in human cells [30]. In fact,
p53 induction and apoptosis are typical outcomes following miR-125b knockdown [31].
Importantly, a significant downregulation of miR-125b and a concomitant increase in
the p53 protein level have been detected in 24 hpf zebrafish embryos exposed to 40 Gy
γ rays, confirming the importance of miR-125b in the modulation of apoptosis in zebrafish
embryos exposed to IR [30].
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In recent years, transgenerational consequences of epigenetic modifications in ze-
brafish, due to IR, have caught the attention of researchers. In this regard, Kamstra JH
et al. [32] studied the relationship between IR-induced changes in DNA methylation and
gene expression, and their persistence over fish generations. In this study, adult fish were
exposed to a total dose of 5.2 Gy for 27 days and maintained for 1 year before generating
F1, F2 and F3 by family inbreeding. Global epigenetic analysis revealed that the chromatin
of F1 embryos, derived from irradiated founder fish, was highly enriched in H3K4me3,
H3K27me3 and H3K4me1 and exhibited higher numbers of differentially methylated re-
gions (DMRs), compared with control embryos. In particular, 62% of the DMRs located
upstream to transcriptional start sites were associated with expressed genes, of which
49% were differentially expressed. Locus-specific analysis on selected genes involved in
metabolic pathways, Wnt signaling, focal adhesion, calcium signaling and MAPK signaling,
revealed that the above-mentioned changes in DNA methylation persisted in the chromatin
of F2 and F3 embryos, highlighting the involvement of DNA methylation in transgenera-
tional effects caused by IR. Martin L. et al. [33] analysed the gamma radiation effect on the
non-coding transcriptome in the first-generation offspring of exposed parents. In particu-
lar, one year after parental exposure (6 months zebrafish, 8.7 mGy/h for 27 days; 5.2 Gy
total dose), fish were mated and non-coding RNA expression profile was analysed in F1
embryos (5.5 hpf) by high-throughput sequencing. Using previous F1-γ genome-wide gene
expression data, hundreds of mRNAs were predicted as targets of differentially expressed
(DE) miRNAs. The DE analysis between F1offspring of gamma-exposed parents and those
of controls showed 22 DE miRNAs, of which 55% were up-regulated and involved in
pathways related to cancer processes, such as the control of pluripotency, proliferation and
metastasis. Also, four out of five major spliceosomal snRNAs (U1, U2, U4, U5) were down-
regulated in the F1-γ group, indicating transcriptional and posttranscriptional alterations.
Accordingly, the expression of the long intergenic noncoding RNAs malat-1—also known
as NEAT2 and well known for its interaction with several serine/arginine proteins, in
order to drive the distribution and function of splicing factors in the nuclear speckles—was
altered in the F1 offspring. Finally, DE piRNA clusters were associated to nine transposable
elements (TEs), and they appeared to be expressed from the complementary strand of
the associated TEs, suggesting that their expression could be in response to the activation
of TEs.
3. Radiation Modifiers in Zebrafish
For all the reasons explained so far, the zebrafish embryo is a suitable model for
large-scale screening of therapeutic agents, such as IR and their modifiers, and it may be
used for easy and rapid testing of novel radiation protectors and sensitizers ultimately
intended for therapeutic use. An updated overview of studies examining these aspects is
reported in Table 1 and discussed in the following section.
Table 1. Summary of the experimental conditions and effects observed using the radiomodifying agents described in this
review. Each column, from left to right, highlights the following aspects: reagent name, reagent role (either radioprotector
or radiosensitizer), concentration used, molecular pathway affected, radiation dose used, and references. * In this case, no
concentration values are indicated because the reagent used was either a genetic mutation (radiosensitizing mutation 7) or a
knocked-down gene (AEG-1).
Reagent Role Concentration Affected Pathways Radiation Dose References
Flavopiridol + HypNA-pPNA Radiosensitizer 0–500 nM + 5 mM Cell cycle, Apoptosis 10–40 Gy γ rays [11]
Temozolomide Radiosensitizer 100 µM DNA damage 10 Gy γ rays [26]
Todralazine Radioprotector 5 µM Oxidative stress 20 Gy γ rays [34]
Metoprolol Radioprotector 5 µM Oxidative stress 20 Gy γ rays [34]
Fullerene derivative DF-1 Radioprotector 100 µM Oxidative stress 20–40 Gy γ rays [35]
Prilocaine hydrochloride Radioprotector 10–40 µM Oxidative stress 20 Gy γ rays [36]
Octopus ocellatus meet (OMA) Radioprotector 62.50–250 µg/mL Oxidative stress 30 Gy γ rays [37]
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Table 1. Cont.
Reagent Role Concentration Affected Pathways Radiation Dose References
L-alpha-Glycerylphosphorylcholine
(GPC) Radioprotector 194–1944 µM
Oxidative stress,
Fibrosis 5–20 Gy γ rays [38]
Phenformin Hydrochloride Radioprotector 25 µM Oxidative stress,Apoptosis 4 Gy X rays [39]




Radiosensitizer 50 µM Oxidative stress,Apoptosis 5–20 Gy γ rays [41]
2-methyl-1,4-naphthoquinone
(Menadione) Radiosensitizer 0–10 µM DNA damage 0.15–1.5 Gy γ rays [42]
4′-bromo-3′-nitropropiophenone
(NS-123) Radiosensitizer 30 µM DNA damage 10 Gy γ rays [43]
Ku70 MOs Radiosensitizer 4–5 ng DNA damage 50 cGy γ rays [44]
Radiosensitizing mutation 7 (rs7) Radiosensitizer - * Apoptosis, DNAdamage 8–15 Gy X rays [45]
Oxofendazole Radiosensitizer 20 µg/mL Cell cycle, Apoptosis,DNA damage 15 Gy γ rays [46]
G ‚O6976 Radiosensitizer 20 µg/mL
Cell cycle, Apoptosis,
DNA damage 15 Gy γ rays [46]
S-nitroso-N-acetylpenicillamine
(SNAP) Radioprotector 20–100 µM Apoptosis 75 mGy X rays [47]
HypNA-pPNA 16-mer Radioprotector 0.5 pmol Cell cycle, Apoptosis 0–40 Gy X rays [48]
pifthrin-a (PFTa) Radioprotector 1 µM Cell cycle, Apoptosis 0–40 Gy X rays [48]
PS-341 Radiosensitizer 1 µM Apoptosis 0–20 Gy X rays [49]
mcherry-BAD mRNA Radiosensitizer 100 ng/µL Apoptosis 15 Gy γ rays [50]
AEG-1 knockdown cells Radiosensitizer - * Migration, invasion 0–10 Gy X rays [51]
Figure 1 depicts the experimental assay generally employed in studies described
below, involving the administration of radiomodifiers pre- [26,34–41,43–50] or post-IR
treatment [42]. Their possible radiosensitizing or radioprotective properties are evaluated
performing a series of analyses at key times during embryogenesis. In particular, the
assessment of mortality, confirmed by the absence of blood circulation or spontaneous
movements within the chorion, begins at 24 hpf. The search for characteristic morpho-
logical alterations—such as micropthalmia, spinal curvature, pericardial edema and the
inhibition of yolk sac resorption—as well as the histopathological assessment, starts at
48 hpf, when there is completion of rapid morphogenesis of primary organ systems, car-
tilage development in head and pectoral fin [52]. Despite heart contraction beginning
approximately at 24 hpf, heart rate evaluation also starts at 48 hpf, when a regular heart-
beat is observed [53]. Although embryo hatching occurs asynchronously from 48 to 72 hpf,
early hatching fish larvae are not more developmentally advanced than those remaining
in their chorion. Consequently, the time of hatching is not always useful as an index of
delayed staging due to a given treatment [52]. Whereas, during the hatching period, the
embryo is usually at rest; the early larvae gradually begin to swim actively and produce
swift escape responses, heralding the seeking of prey and feeding [52]. For this reason,
evaluation of behavioral changes starts from 120 hpf, either by using a manual test, such as
the touch-evoked response and locomotion assay [54], or by an automated video-tracking
solution. Apoptosis assessment could be done directly through the immunofluorescence
assay for CASP-3, Tunel assay or by in vivo staining with the fluorescent dye acridine
orange [55,56]. To evaluate the extent of DNA damage, some researchers propose the search
for γ-H2AX or 53BP1 foci by immunofluorescence assay, while others prefer to evaluate
the variation in the expression level of key molecules belonging to specific DNA-repair
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pathways by means of immunofluorescence and Western blotting assay [57,58]. The same
experimental approach is used to indirectly evaluate oxidative stress, by analyzing the
expression levels of the main enzymes involved in the detoxification pathway or hydroxyl
radical and superoxide anion scavenging activity [59].
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Figure 1. Diagrammatic representation of the experimental assays employed in the studies described
in this review.
This overview below is subdivided into distinct subparagraphs according to the main
biological processes affected by a given radio-protector/sensitizer used, namely oxidative
stress, DNA damage and apoptosis.
3.1. xidative Stress
ROS and reactive nitrogen species (RNS) are produced by intracellular water radiolysis,
due to beam interaction. Free radicals, such as OH•, O2•− and HO2•, play a central role in
both DNA-damaging and -repair impairment, protein oxidation and lipid peroxidation,
causing cytotoxicity associated with cell cycle arrest, apoptosis or necrosis [60]. On the
other hand, ROS formation also induces adverse effects on normal cells and tissues, by
means of inflammation, which is the main pathogenic consequence of RT sequelae [61].
Although the ROS-induced damage associated with irradiation depends on several factors,
such as the LET value, the dose and the dose rate used during irradiation and the intrinsic
radiosensitivity of target tissue [62], the accumulation of ROS is physiologically limited by
specific cellular systems involving glutathione metabolism and dedicated enzymes, such
as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidases [63].
Considering that this phenomenon can differentially influence the response to an
RT treatment, some studies have the effects of in vivo pretreatment with radioprotec-
tive/radiosensitizing molecules involved in this process. For example, a 30 min pre-
irradiation treatment of 24 hpf zebrafish embryos with the antihypertensive Todralazine
significantly reduced the rate of morphological alterations due to IR, and protected em-
bryos from lethality [34]. Indeed, while irradiation alone caused a 1.85-fold increase of
ROS levels, Todralazine pretreatment reduced this value to 1.56-fold [34].
Similarly, it was observed that 3 h of pre-IR treatment with the fullerene derivative
DF1 increased the survival rate of 6 dpf irradiated zebrafish juveniles from 40% to 85% [35].
Moreover, the incidence of the “cup” phenotype was reduced from 65% to 10% and from
70% to 35%, for exposure to 20 and 40 Gy, respectively. Additional evaluations highlighted
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a protective action on renal and nervous system, with a clearance increase of 30% and a
reduction of developing nerve cells in zebrafish. ROS levels, evaluated at zero and 2 h
post-IR, decreased in the pre-treated embryos, with values of 0.7 vs. 1 for the former time
point and 1.2 vs. 2.3 for the other [35].
A variation in the hydroxyl radical and superoxide anion-scavenging activity was also
evaluated by Dimri L. et al. [36], who studied the effect induced in 20 hpf embryos under
30 min of pre-IR treatment with the anesthetic prilocaine hydrochloride, an intermediate-
acting local anesthetic of the amide type chemically related to lidocaine. First, the addition
of this compound led to a more than 85% reduction in all mild adverse effects due to
irradiation, and 60% in embryo mortality at 4 days post-irradiation (dpi). Moreover,
prilocaine-treated embryos did show significantly enhanced erythropoiesis, suggesting a
specific effect on the hematopoietic stem-cell lineage [36].
Lee WW et al. [37] examined the antioxidant effect of the aqueous extract from octopus
ocellatus meat (OMA) on 24 hpf zebrafish embryos before irradiation. They found that
the survival rate was markedly improved (75%–80%) in the pretreated and irradiated
embryos, compared with the irradiated ones (40%), and that no abnormal tail bending
was exhibited by pretreated and irradiated embryos. In addition, OMA pretreatment
significantly reduced both ROS and NO levels in a dose-dependent manner [37], thus
demonstrating that a simple and easily available food extract can protect against adverse
effects induced by radiation.
In a distinct study, the protective activity of L-alpha glycerylphosphorylcholine (GPC)
was tested in zebrafish embryos at 6 and 24 hpf [38]. In particular, while embryos irradiated
with 20 Gy started to die at day 3 and had all died by day 5 post-irradiation, embryos pre-
treated with GPC and exposed to the same radiation dose were still alive at the same point
in time. Histopathological assessment on irradiated fish highlighted severe alterations in
the gastrointestinal system, including large amounts of mucus and catarrh in the intestinal
flux, with goblet cells found in the intestinal mucous membrane, where cells had irregular
shapes and larger hyperchromatic nuclei in a wider cytoplasm. All these alterations were
attenuated and partially restored by GPC pretreatment, confirming the results of previous
in vitro and in vivo studies about the GPC protective role against lethality and multi-organ
morphological and histological impairment [64–66].
Another study reported that, in comparison with the irradiation-alone group, pre-
exposure of 4 hpf zebrafish embryos to the antidiabetic phenformin hydrochloride signif-
icantly increased both their survival and hatching rates, and reduced the malformation
incidence at 24 and 48 hpf, by preventing the deficit in spontaneous movement and heart
rate [39]. In addition, phenformin pretreatment reversed the gene-expression variations as-
sociated with IR, restoring the normal cellular abundance of SOD, CAT, acetylcholinesterase
and malondialdehyde, while leading to upregulation of BDNF and bcl-2 expression, and
downregulation of p53, BAX and γ-H2AX [39].
Encouraging results were also reached with CO-releasing molecules (CORMs), widely
known to alleviate toxicity from oxidative stress. For example, pretreatment of 4 hpf
zebrafish embryos with CORM-3 increased their hatching rate and reduced the incidence of
mortality at 72 and 120 hpf, compared with the only irradiated group [40]. The evaluation
of spontaneous movement and larval behavior at 24 and 144 hpf highlighted that CORM-3
pretreatment afforded a significant behavioral advantage, compared with larvae from the
only irradiated group. ROS levels were reduced by CORM-3 pretreatment, while SOD
and CAT activities were increased. Acridine orange staining also revealed that apoptosis,
induced by irradiation, was strongly reduced by CORM-3 pretreatment, likely due to the
increase in bcl-2 and decrease in BAX, caspase-9 and caspase-3 mRNA levels. Being an
efficient ROS scavenger, CORM-3 could suppress ROS production, alleviating the toxicity
rate induced by X ray irradiation [40].
Further studies have reported preliminary findings. For example, Geng L. et al.
evaluated the radiosensitizing effects of pretreatment with VJ115, an inhibitor of ENOX1’s
NADH oxidase activity previously tested on Lewin’s lung carcinoma and HT29 xenograft
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models. Whereas IR exposure of 24 hpf zebrafish embryos did not affect their ability to
hatch between 48 and 72 hpf, VJ115 pretreatment resulted in a dose-dependent hatching
inhibition [41,66].
Similarly, exposure of 6 hpf-zebrafish irradiated embryos to the synthetic organic com-
pound menadione (2-methyl-1,4-naphthoquinone) exacerbated the RT effect, as evidenced
by higher developmental defects and higher TUNEL-staining in embryos exposed to the
combined treatment [42]. However, additional study isrequired to confirm the potential
therapeutic use of these agents as radiosensitizers.
3.2. DNA Damage
Being the most sensitive macromolecule to IR, DNA is certainly the main target of
cellular damage. In general, minor DNA damage is thought to halt cell cycles allowing
effective repair, while more severe damage can induce an apoptotic cell-death program [67].
Lally BE et al. used zebrafish embryos as a U251 xenograft model to test the in vivo
radiosensitizing effect of the DNA repair inhibitor 4′-bromo-3′-nitropropiophenone (NS-
123) [43]. In particular, 24 hpf embryos bearing fluorescently labelled U251 xenograft
tumors were incubated with NS-123 for 14 h, before exposure to 10 Gy γ rays. As reported,
NS-123 pretreatment specifically provoked a marked regression of the xenograft size, mea-
sured as extinction of the xenograft fluorescence at 3 or 5 dpf. Immunoblotting assays also
revealed substantially higher levels of γ-H2AX, P-CHK2, P-DNA-PKcs and P-ATM in U251
cells that endured the combined treatment compared to irradiated experimental groups,
suggesting that unrepaired DSBs accumulate in the presence of NS-123. Accordingly,
control DMSO-treated U251 cells showed almost complete repair of double strand breaks
(DSBs) at 24 h (∼9% of their initial damage), while NS-123-treated cells showed ∼25% of
their initial damage [43].
Temozolomide is a drug widely known for its antineoplastic cytotoxicity related to
the perturbation of DNA repair [68]. Using an approach similar to that described for
NS-123, it has been reported that the treatment of zebrafish embryos bearing fluorescently
labelled glioma cell transplants with temozolomide, followed by exposition to 10 Gy γ-rays,
significantly decreased the tumor size at 3 and 5 dpf, with complete eradication of tumor
masses in 21% of the embryos [26].
The most dangerous lesions directly inflicted by IR on DNA are DSBs, which can
increase the recurrence of chromosomal translocation and genome mutation [69]. DSBs are
repaired by two main mechanisms, namely homologous recombination and nonhomolo-
gous end joining (NHEJ), both involving the concurrent triggering of complex signaling
networks often connected to each other [58,70]. Notably, the spatial expression pattern of
zebrafish Ku70, a component of the NHEJ pathway, suggests a role for this DNA repair
protein in the differentiation of neural tissue [17,71]. In order to evaluate its potential
sensitizing role, Ku70 knockdown was imposed by microinjection of antisense morpholino
oligonucleotides (MO) into the yolk of one-cell zebrafish embryos [44]. In particular, two
distinct oligonucleotides were designed, one complementary to the Ku70 translation initia-
tion site (atgMO) and the other complementary to the splice donor sequence of intron 2
(sd2MO), and their effects were compared to those of a control oligonucleotide. Injected
embryos were irradiated (50 cGy γ rays) at 6 hpf and TUNEL-assayed at 24 hpf. In contrast
wth non-irradiated control embryos, irradiation of embryos microinjected with atgMO re-
sulted in profound developmental defects and cell death, associated with elevated amounts
of TUNEL-positive cells in the central nervous system, retina and tail. Similar effects were
also detected in embryos injected with sd2MO, although their phenotype was consistently
less severe, and the overall amount of TUNEL staining was reduced [44]. These results
suggest that Ku70 knockdown is sufficient to modify radiosensitivity in vivo, and that Ku70
plays a crucial role in protecting the differentiating nervous system from radiation-induced
DNA damage during zebrafish embryogenesis.
In this respect, another research group tested the apoptotic effect on neural tissue
caused by exposure of 24 hpf zebrafish embryos to high doses of IR, in the range of
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8–15 Gy [45]. In particular, they performed a recessive genetic screening, using 8 Gy X rays,
and identified a number of mutations that could sensitize embryos to IR, among which
the main character was the radiosensitizing mutation 7 (rs7). This mutation causes major
deterioration of neural tissue, leading to a small-head and curled-tail phenotype by 2 dpf,
and death by the end of 3 dpf. To verify the relation between neural cell death and apoptosis
in irradiated rs7 mutants, the authors performed immunofluorescence at 6 h post-IR to
detect active caspase-3. In this assay, irradiated rs7 mutants showed a dramatic increase
in cell death in the neural tissue when compared to wild-type irradiated embryos, with
a 95-fold increase in active-Caspase-3 staining. Having identified that the rs7 mutation
consisted in the presence of premature stop codon in the coiled-coil domain containing
gene 94 (ccdc94), they injected embryos, derived from a cross between rs7 heterozygotes
with synthetic mRNA encoding either zebrafish ccdc94, human ccdc94 or egfp (as a control),
and exposed the resulting embryos to 8 Gy X rays. Importantly, embryos injected with
zebrafish or human ccdc94 mRNA fully rescued the rs7 radiosensitization phenotype [45].
The protein expressed by ccdc94 is a functional component of the Prp19 complex, that,
in vertebrate cells, has established roles in pre-mRNA-splicing and DNA-repair pathway,
regulating the p53 expression. Therefore, this study shows that depleting components of
the Prp19 complex sensiti to DNA damage.
A more recent study reported that embryos derived from homozygous tp53M214K
zebrafish mutants are associated with a complete lack of dorsal tail curvature and cell-
death induction in response to IR [46]. Importantly, inhibitors of checkpoint kinase 1,
such as oxfendazole, efficiently radiosensitized tp53M214K mutants with minimal toxicity,
and their effect was shown to be apoptotic in nature, as revealed by acridine orange,
TUNEL and active CASPASE-3 stains of 48 hpf embryos. In addition, it was associated
with an increase in DNA damage in a dose- and time-dependent manner, with maximal
efficacy when administered 0–4 hpi. Moreover, the similarity-ensemble approach—a target-
prediction algorithm—identified, as novel targets, the interleukin-1 receptor-sssociated
kinases (IRAK) 1 and 4, whose inhibition by IRAK1/4 inhibitor (IRAK1/4i) was able to
radiosensitize tp53M214K embryos. IRAK1 is known to be an effector of IL-1R and TLRs in
innate immune signaling, acting in pro-survival and inflammatory responses to pathogens.
Indeed, experimental inhibition of one of its additional candidate targets, as the peptidyl-
prolyl cis/trans isomerase PIN142, radiosensitized zebrafish tp53M214K mutants, with
similar potency to that of IRAK1/4i [46].
3.3. Apoptosis
Although most of DNA damage is correctly repaired, it is well known that the repair
process often results in small deletions or insertions at the breakpoints, loss of heterozygos-
ity and chromosomal translocations [72–74]. These rearrangements might be inconsequen-
tial or they may promote cell death or cancer initiation, depending on their location in the
genome [75].
In a recent study, E.Y. Kong et al. evaluated the influence of exogenous NO, generated
using the NO donor S-nitroso-N-acetylpenicillamine (SNAP), on X-ray-induced targeted
and non-targeted bystander effects in zebrafish embryos [47]. They found that SNAP
treatment of 5 hpf zebrafish embryos, followed by irradiation with 75 mGy X rays, resulted
in a slight reduction in the mean number of apoptotic events, detected by acridine orange
vital staining at 24 hpf, compared with that obtained in the only irradiated embryos at
the same stage. However, when unirradiated 3 hpf embryos were pretreated with SNAP,
transferred into fresh culture medium, and eventually partnered with the only irradiated
embryos until they reached the 24 hpf stage, the mean number of apoptotic events on the
SNAP treated embryos was significantly lower [47].
Duffy KT et al. studied the p53 role, testing the effect of pre-IR treatment of early
zebrafish embryos with hydroxylprolyl-phosphono peptide nucleic acid (HypNA-pPNA)
hetero-oligomers targeting tp53 mRNA or with the inhibitor of p53 transactivation activity
pifithrin-α (PFT-α) [48]. While 100% of only irradiated embryos showed a characteristic
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aberrant dorsal curvature at 48 hpf and a 100% mortality rate at 144 hpf, embryos pre-
treated with HypNA-pPNA were normal and mostly viable at all IR doses (0–40 Gy) used.
By contrast, embryos pretreated with PFT-α and irradiated, died by 120 hpf, highlighting
different mechanisms of the two molecules on p53 related apoptosis.
In a distinct study, PFT-α was used in combination with PS-341, a radiosensitizer
known to abrogate the TNFα-induced NF-κB activity [76,77]. A preliminary experiment
showed that pre-IR exposure of 24 hpf zebrafish embryos with PS-341 consistently reduced
the survival rate at 7 dpi [49]. Then, p53 was knocked down, by injecting antisense
morpholino oligonucleotides in developing zebrafish embryos or exposing them to PFT-α,
to inhibit the p53 transactivation activity before embryo irradiation. The latter treatment
markedly improved zebrafish survival after irradiation, either alone or in combination
with PS-341. RT-PCR analysis did not reveal increased mRNA levels of the p53 targets
p21/WAF1, bax or mdm2 in PS-341 treated embryos, whereas IR led, as expected, to
elevated transcript levels for these genes [49]. Thus, the molecular targets responsible for
radiosensitization by PS-341 and their relationship to p53 remain to be identified.
Considering its ability to enhance radiation-induced apoptosis in in vitro assays, the
mammalian pro-apoptotic BAD was overexpressed by Jette CA et al. as an mCherry-BAD
fusion protein in zebrafish developing embryos, exposing them to 15 Gy γ rays at 24 hpf,
and measuring CASP-3 activity [50]. As expected, irradiated embryos overexpressing
mcherry-BAD showed a greater level of activated CASP-3 throughout the brain and spinal
cord compared with only irradiated embryos. In addition, overexpression of a mCherry-
BAD protein bearing a mutation in the BH3 domain led to apoptotic levels to those of only
irradiated embryos, demonstrating that the BAD-dependent enhancement of radiation-
induced apoptosis requires a functional BH3 domain.
McAleer MF et al. used zebrafish embryos to compare the effects on the radiation
response of flavopiridol to those associated with cyclin D1 (ccnd1) knock down by anti-
sense HypNApPNA oligomers [11]. Flavopiridol pretreatment resulted in a “curly up”
phenotype at a lower radiation dose, compared with only irradiated embryos, and in
dramatic increase in embryo lethality at 120 hpf. Similar outcomes were obtained following
the injection of ccnd1-specific HypNA-pPNA oligomers, supporting the hypothesis that
cyclin D1 inhibition is sufficient to account for the radiosensitizing effects of flavopiridol in
zebrafish embryos.
4. Conclusions and Perspectives
Over the past decades, the combination of chemotherapy and radiotherapy has become
the standard modality for treatment for many solid tumors at certain stages, from brain
to pelvis, head and neck, bladder, anal and advanced cervical cancers, and, to varying
degrees, in gastric and pancreatic cancer, glioblastoma and sarcomas, improving overall
survival [78].
In general, chemotherapy and other radiosensitizers, administered as neoadjuvant
treatment to RT, are used with the aim of obtaining a modification of the slope of the
dose-response curve and to prevent or delay metastasis, thanks to their systemic effects.
The drugs’ and radiations’ action mechanisms can be different, thus the two therapies could
act independently. However, in most cases, their effects are additive (combined action
on the same target, with radio-enhancing effect) or synergistic (where the final effect’s
magnitude is more than can be explained additively).
In the combined chemo–radio-therapy treatment, the drug could have disparate molec-
ular mechanisms; however, in various ways, they act by participating ino the (I) inhibition
of the sublethal damage recovery; (II) inhibition of repopulation; (III) enhancing sensitivity
of hypoxic cells; and (IV) promoting cell cycle synchronization in phases more sensitive to
RI [79]
However, if the rationale for therapeutic combinations is to increase their local effect,
the increase of cytotoxic effects is inevitable and, in some cases, not always tolerable, thus,
in recent years the interest for more tolerable radiomodifiers has grown.
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This review provides an updated overview of the state of the art on the use of the
zebrafish embryo model for testing radiomodifier molecules in combination with RT. All
examined studies confirm that the zebrafish is an excellent vertebrate model for experimen-
tal validation and optimization in the field of radiobiological research. Indeed, zebrafish
have both a full complement of vertebrate-specific organs of radiobiological interest and
an irradiation size useful for detailed investigations on RBE–LET correlation. Worth men-
tioning, zebrafish embryos are permeable to a wide range of molecules, and the use of
fish-larvae xenografts, which allow us to assess tumorigenicity of human cancer cells
irradiated in vivo [51].
A common finding from all the studies described in this review is that radioprotectors
mainly act by reducing oxidative stress, while radiosensitizers act through many other
and, often, related mechanisms. It follows that the identification and characterization of
these mechanisms could be helpful for the development of novel combined therapeutic
strategies aimed at minimizing the side effects induced by radiation on healthy tissue,
while, concomitantly, improving the selective targeting of tumor tissues.
Remarkably, studies adequately exploring the transgenerational effects of IR in ze-
brafish are still missing. Future investigation on this point is needed, especially considering
the growing use of radiation for cancer treatment in subjects of childbearing age, where
the concept of genomic instability inherited from offspring must necessarily be explored.
The finding of delayed and persistent hereditary effects caused by parental irradiation—
mostly expressed as increased ROS formation, DNA damage and bystander effects in the
offspring—highlights the need for further study to provide information on the potential
transgenerational effects induced by RT protocols, as well as on the environmental impact
of IR. Once again, zebrafish would be the best choice for in-depth study in this field,
predominantly because of its conservation in DNA repair and epigenetic mechanisms.
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dpi days post irradiation
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